GlassScriptPhysician profile
Joelle Vital
NPI 1013070176
$4,403.56
in general payments reported to CMS, 2019-2025
19 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,679 · 2021: $232 · 2022: $314 · 2023: $154 · 2024: $610 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,454.00 | 2019 | |
| Amgen INC. | $487.51 | 2019-2025 | Repatha, Otezla, Repatha |
| Novo Nordisk INC | $389.45 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $299.09 | 2019-2022 | |
| Renalytix Ai, INC. | $161.54 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Lilly USA, LLC | $92.65 | 2022-2024 | Jardiance, Mounjaro |
| Mannkind Corporation | $87.33 | 2023-2025 | Afrezza |
| Merck Sharp & Dohme LLC | $62.52 | 2019 | |
| Lundbeck LLC | $58.26 | 2024-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $53.52 | 2022 | |
| Eisai INC. | $48.39 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $43.47 | 2024 | Rexulti |
| Intuity Medical INC | $41.85 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.14 | 2019 | |
| Grt US Holding, INC. | $24.16 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $23.70 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Currax Pharmaceuticals LLC | $17.87 | 2025 | Contrave |
| Glaxosmithkline, LLC. | $17.24 | 2019 | |
| Amarin Pharma, INC. | $15.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joelle Vital listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.